Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells, 2nd Edition
This document provides performance guidelines for the immunophenotypic analysis of neoplastic hematolymphoid cells using immunofluorescence-based flow cytometry; for sample and instrument quality control; and precautions for acquisition of data from neoplastic hematolymphoid cells.
This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of June 2017. The document’s next scheduled review is generally five years after the reaffirmation date.
This document is available in electronic format only.
Member price:List Price:
Chairholder: Maryalice Stetler-Stevenson, MD, PhD
Date of Publication: April 23, 2007
Order Code PDF: CLSI H43A2E
ISBN Number: 1-56238-635-2
Order Code Print: print not available
CLSI H43 Additional Details
If interested in ordering larger quantities of this document in print, please contact us here.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.